Continuing Education Risk-adapted Therapy for PV Jerry L. Spivak, MD, MACP

What are MPNs? What are Myeloproliferative neoplasms (MPNs)?

FAQ How is red blood cell (RBC) transfusion used to manage anemia in myelofibrosis (MF) patients? Srdan Verstovsek, MD, PhD

FAQ How can the mutational profile in myeloproliferative neoplasms (MPN) help to inform diagnosis and prognosis? Aaron T. Gerds, MD, MS

FAQ How is risk assessed in PV and how does this risk inform treatment decisions? Jerry L. Spivak, MD, MACP

FAQ What are the treatment options for MF-related anemia? Raajit K. Rampal, MD, PhD View all FAQs